Stocktoria
PMGC Holdings Inc. ELAB
PMGC Holdings Inc. (ELAB) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $590,084 at a -1313.0% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ELAB | PMGC Holdings Inc. | 2/9 | — | — | — |
| VCNX | VACCINEX, INC. | 3/9 | — | — | — |
| VYNE | VYNE Therapeutics Inc. | 2/9 | — | — | — |
| SLN | Silence Therapeutics plc | 1/9 | -12.42 | — | -98.7% |
| BTAI | BioXcel Therapeutics, Inc. | 2/9 | — | — | — |
| QUCY | Quantum Cyber N.V. | 3/9 | — | — | — |
| MREO | Mereo BioPharma Group plc | 3/9 | — | — | — |
About PMGC Holdings Inc.
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
FAQ
Is ELAB financially healthy?
PMGC Holdings Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does ELAB pay a dividend?
No, PMGC Holdings Inc. does not currently pay a dividend.
How profitable is ELAB?
In FY2025, PMGC Holdings Inc. had a net margin of -1313.0% and a return on equity of -98.9%.
Is ELAB a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on PMGC Holdings Inc.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.